SITALA Trademark

Trademark Overview


On Thursday, May 19, 2022, a trademark application was filed for SITALA with the United States Patent and Trademark Office. The USPTO has given the SITALA trademark a serial number of 79348421. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by Sitala Bio Ltd. The SITALA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medicinal preparations for the prevention and treatment of chronic inflammation, inflammation and inflammatory diseases; medicinal substances for the prevention and treatment of chronic inflammation, inflammation and inflammatory diseases

Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; laboratory research services in the field of pharmaceuticals; clinical research in the field of chronic inflammation, inflammation and inflammatory diseases; medical research; conducting of clinical trials for pharmaceutical products in the field of chronic inflammation, inflammation and inflammatory diseases; pharmaceutical product evaluation services; testing of pharmaceuticals; pharmaceutical research and development services; information, consultancy and advisory services relating to all of the aforesaid
sitala

General Information


Serial Number79348421
Word MarkSITALA
Filing DateThursday, May 19, 2022
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7256721
Registration DateTuesday, January 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Goods and ServicesPharmaceutical and medicinal preparations for the prevention and treatment of chronic inflammation, inflammation and inflammatory diseases; medicinal substances for the prevention and treatment of chronic inflammation, inflammation and inflammatory diseases
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; pharmaceutical drug development services; laboratory research services in the field of pharmaceuticals; clinical research in the field of chronic inflammation, inflammation and inflammatory diseases; medical research; conducting of clinical trials for pharmaceutical products in the field of chronic inflammation, inflammation and inflammatory diseases; pharmaceutical product evaluation services; testing of pharmaceuticals; pharmaceutical research and development services; information, consultancy and advisory services relating to all of the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 2, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSitala Bio Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameSitala Bio Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameSitala Bio Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, April 5, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 4, 2024FINAL DISPOSITION PROCESSED
Tuesday, April 2, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Monday, October 16, 2023NOTIFICATION PROCESSED BY IB
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 27, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 6, 2023REFUSAL PROCESSED BY IB
Friday, May 12, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 12, 2023REFUSAL PROCESSED BY MPU
Friday, March 24, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 23, 2023NON-FINAL ACTION WRITTEN
Thursday, March 9, 2023ASSIGNED TO EXAMINER
Tuesday, January 10, 2023CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Monday, October 24, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, September 6, 2022APPLICATION FILING RECEIPT MAILED
Friday, September 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 1, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB